Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy. The PzF Shield Trial

NCT01925794 is registered in ClinicalTrials.gov with CeloNova BioSciences, Inc. as lead sponsor.

NCT NCT01925794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01925794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy. The PzF Shield Trial
Lead sponsor
CeloNova BioSciences, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 21, 2013
Completion date
March 2, 2020
Enrollment
296 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease